| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |